Sunday, January 16, 2011

AMEDEO Bacterial Infections and Mycoses: Your January Journal Article Summary

AMEDEO Bacterial Infections and Mycoses 


2011-01-17

Your Personal Amedeo Web Page:


________________ ** New articles **  _________________


1. SHAW JL, Wills GS, Lee KF, Horner PJ, et al.
Chlamydia trachomatis Infection Increases Fallopian Tube PROKR2 via TLR2 and
NFkappaB Activation Resulting in a Microenvironment Predisposed to Ectopic
Pregnancy.
Am J Pathol. 2011;178:253-60.
ABSTRACT available


2. BASU S, Stuckler D, McKee M.
Addressing institutional amplifiers in the dynamics and control of tuberculosis
epidemics.
Am J Trop Med Hyg. 2011;84:30-7.
ABSTRACT available


3. GADODIA A, Sharma R, Jeyaseelan N.
Tuberculous abdominal cocoon.
Am J Trop Med Hyg. 2011;84:1-2.



4. MCGREADY R, Wuthiekanun V, Ashley EA, Tan SO, et al.
Diagnostic and treatment difficulties of pyelonephritis in pregnancy in
resource-limited settings.
Am J Trop Med Hyg. 2010;83:1322-9.
ABSTRACT available


5. MILAGRES BS, Padilha AF, Barcelos RM, Gomes GG, et al.
Rickettsia in synanthropic and domestic animals and their hosts from two areas of
low endemicity for Brazilian spotted fever in the eastern region of Minas Gerais,
Brazil.
Am J Trop Med Hyg. 2010;83:1305-7.
ABSTRACT available


6. CHEN CI, Clark DC, Pesavento P, Lerche NW, et al.
Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a
pregnant Rhesus macaque model.
Am J Trop Med Hyg. 2010;83:1249-58.
ABSTRACT available


7. DELIGNY C, Arfi S.
Images in clinical tropical medicine. Pseudochondritis in leprosy.
Am J Trop Med Hyg. 2010;83:1175.



8. LEE YS, Shin YP, Shin SH, Park S, et al.
Therapeutic Efficacy of Halocidin-Derived Peptide HG1 in a Mouse Model of
Surgical Wound Infection with Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2011.
ABSTRACT available


9. DE KRAKER ME, Wolkewitz M, Davey PG, Grundmann H, et al.
The clinical impact of antimicrobial resistance in European hospitals: excess
mortality and length of hospital stay related to methicillin resistant
Staphylococcus aureus bloodstream infections.
Antimicrob Agents Chemother. 2011.
ABSTRACT available


10. ROBERT J, Tristan A, Cavalie L, Decousser JW, et al.
PVL-positive and TSST-1-positive methicillin-resistant Staphylococcus aureus: a
French multicenter prospective study in 2008.
Antimicrob Agents Chemother. 2011.
ABSTRACT available


11. MCCALLUM N, Stutzmann Meier P, Heusser R, Berger-Bachi B, et al.
Mutational analyses of ORFs within the vraSR operon and their roles in the cell
wall stress response of Staphylococcus aureus.
Antimicrob Agents Chemother. 2011.
ABSTRACT available


12. LIU C.
The Bundled Approach to MRSA Surgical Site Infection Prevention: Is the Whole
Greater Than the Sum of Its Parts?: Comment on "Sustained Reduction in
Methicillin-Resistant Staphylococcus aureus Wound Infections After Cardiothoracic
Surgery".
Arch Intern Med. 2011;171:73-4.



13. OAKE N, Taljaard M, van Walraven C, Wilson K, et al.
The effect of hospital-acquired Clostridium difficile infection on in-hospital
mortality.
Arch Intern Med. 2010;170:1804-10.
ABSTRACT available


14. BHUNIYA S, De P.
Questions in the role of chest CT scanning in TB outbreak investigation.
Chest. 2010;138:1522-3.



15. GHEORGHE C, Dadu R, Blot C, Barrantes F, et al.
Hyperchloremic metabolic acidosis following resuscitation of shock.
Chest. 2010;138:1521-2.



16. EL-SOLH AA, Niederman MS, Drinka P.
Management of pneumonia in the nursing home.
Chest. 2010;138:1480-5.
ABSTRACT available


17. SCHLUGER NW, Burzynski J.
Recent advances in testing for latent TB.
Chest. 2010;138:1456-63.
ABSTRACT available


18. GUNTUPALLI KK, Gutterman D, Raoof S, Markowski PA, et al.
2010: the year of the lung.
Chest. 2010;138:1287-8.



19. LIU C, Bayer A, Cosgrove SE, Daum RS, et al.
Clinical practice guidelines by the infectious diseases society of america for
the treatment of methicillin-resistant Staphylococcus aureus infections in adults
and children: executive summary.
Clin Infect Dis. 2011;52:285-92.
ABSTRACT available


20. ZHANG J, Mao Z, Xue W, Li Y, et al.
Ku80 Gene is Related to Non-Homologous End-Joining and Genome Stability in
Aspergillus niger.
Curr Microbiol. 2011.
ABSTRACT available


21. ABACI O.
Investigation of Extracellular Phospholipase and Proteinase Activities of Candida
Species Isolated from Individuals Denture Wearers and Genotypic Distribution of
Candida albicans Strains.
Curr Microbiol. 2011.
ABSTRACT available


22. LI X, Liu X, Zou Y, Ouyang C, et al.
Erratum to: Predictors of Clinical and Endoscopic Findings in Differentiating
Crohn's Disease from Intestinal Tuberculosis.
Dig Dis Sci. 2011.



23. NHAN TX, Leclercq R, Cattoir V.
Prevalence of toxin genes in consecutive clinical isolates of Staphylococcus
aureus and clinical impact.
Eur J Clin Microbiol Infect Dis. 2011.
ABSTRACT available


24. LIAKOPOULOS A, Foka A, Vourli S, Zerva L, et al.
Aminoglycoside-resistant staphylococci in Greece: prevalence and resistance
mechanisms.
Eur J Clin Microbiol Infect Dis. 2011.



25. KRISTOF K, Kocsis E, Szabo D, Kardos S, et al.
Significance of methicillin-teicoplanin resistant Staphylococcus haemolyticus in
bloodstream infections in patients of the Semmelweis University hospitals in
Hungary.
Eur J Clin Microbiol Infect Dis. 2011.
ABSTRACT available


26. BRADY RA, O'May GA, Leid JG, Costerton JW, et al.
Resolution of Staphylococcus aureus biofilm infection using vaccination and
antibiotic treatment.
Infect Immun. 2011.
ABSTRACT available


27. SYRE H, Grewal H.
Isoniazid and rifampicin resistance-associated mutations in Mycobacterium
tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular
testing-authors' response.
J Antimicrob Chemother. 2011.



28. MORAN E, Byren I, Atkins BL.
The diagnosis and management of prosthetic joint infections.
J Antimicrob Chemother. 2010;65 Suppl 3:iii45-54.
ABSTRACT available


29. DRYDEN MS.
Complicated skin and soft tissue infection.
J Antimicrob Chemother. 2010;65 Suppl 3:iii35-44.
ABSTRACT available


30. POWLSON AS, Coll AP.
The treatment of diabetic foot infections.
J Antimicrob Chemother. 2010;65 Suppl 3:iii3-9.
ABSTRACT available


31. PALLETT A, Hand K.
Complicated urinary tract infections: practical solutions for the treatment of
multiresistant Gram-negative bacteria.
J Antimicrob Chemother. 2010;65 Suppl 3:iii25-33.
ABSTRACT available


32. GOULIOURIS T, Aliyu SH, Brown NM.
Spondylodiscitis: update on diagnosis and management.
J Antimicrob Chemother. 2010;65 Suppl 3:iii11-24.
ABSTRACT available


33. LUO S, Blom AM, Rupp S, Hippler UC, et al.
The pH regulated antigen 1 of Candida albicans binds the human complement
inhibitor C4b-binding protein and mediates fungal complement evasion.
J Biol Chem. 2011.
ABSTRACT available


34. GAO JL, Nguyen KA, Hunter N.
Characterization of a hemophore-like protein from Porphyromonas gingivalis.
J Biol Chem. 2010;285:40028-38.
ABSTRACT available


35. OKWAN-DUODU D, Datta V, Shen XZ, Goodridge HS, et al.
Angiotensin-converting enzyme overexpression in mouse myelomonocytic cells
augments resistance to Listeria and methicillin-resistant Staphylococcus aureus.
J Biol Chem. 2010;285:39051-60.
ABSTRACT available


36. FREITAS AR, Coque TM, Novais C, Hammerum AM, et al.
Human and Swine Hosts Share Vancomycin-Resistant Enterococcus faecium CC17, CC5,
and Enterococcus faecalis CC2 Clonal Clusters Harboring Tn1546 on
indistinguishable plasmids.
J Clin Microbiol. 2011.
ABSTRACT available


37. PFALLER MA, Espinel-Ingroff A, Boyken L, Hollis RJ, et al.
Comparison of the broth microdilution (BMD) method of the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) with the 24-h CLSI BMD method for
fluconazole, posaconazole, and voriconazole susceptibility testing of Candida
species using epidemiological cutoff values.
J Clin Microbiol. 2011.
ABSTRACT available


38. MILLON L, Grenouillet F, Legrand F, Loewert S, et al.
Ribosomal and mitochondrial DNA target for real-time PCR diagnosis of invasive
aspergillosis.
J Clin Microbiol. 2011.
ABSTRACT available


39. NETT JE, Cain MT, Crawford K, Andes DR, et al.
Optimizing a Candida biofilm microtiter plate model for measurement of antifungal
susceptibility by XTT assay.
J Clin Microbiol. 2011.
ABSTRACT available


40. CRACIUN FL, Schuller ER, Remick DG.
Early Enhanced Local Neutrophil Recruitment in Peritonitis-Induced Sepsis
Improves Bacterial Clearance and Survival.
J Immunol. 2010.
ABSTRACT available


41. ZHANG J, Yang L, Ang Z, Yoong SL, et al.
Secreted M-ficolin anchors onto monocyte transmembrane G protein-coupled receptor
43 and cross talks with plasma C-reactive protein to mediate immune signaling and
regulate host defense.
J Immunol. 2010;185:6899-910.
ABSTRACT available


42. HAMILTON SE, Schenkel JM, Akue AD, Jameson SC, et al.
IL-2 complex treatment can protect naive mice from bacterial and viral infection.
J Immunol. 2010;185:6584-90.
ABSTRACT available


43. MCCOY AJ, Koizumi Y, Higa N, Suzuki T, et al.
Differential regulation of caspase-1 activation via NLRP3/NLRC4 inflammasomes
mediated by aerolysin and type III secretion system during Aeromonas veronii
infection.
J Immunol. 2010;185:7077-84.
ABSTRACT available


44. YANG Z, Wang ZE, Doulias PT, Wei W, et al.
Lymphocyte development requires S-nitrosoglutathione reductase.
J Immunol. 2010;185:6664-9.
ABSTRACT available


45. HALE JS, Wubeshet M, Fink PJ.
TCR revision generates functional CD4+ T cells.
J Immunol. 2010;185:6528-34.
ABSTRACT available


46. MOORE C, Galiano M, Lackenby A, Abdelrahman T, et al.
Evidence of Person-to-Person Transmission of Oseltamivir-Resistant Pandemic
Influenza A(H1N1) 2009 Virus in a Hematology Unit.
J Infect Dis. 2011;203:18-24.
ABSTRACT available


47. HIRSCH MS.
A new publisher for the Journal of Infectious Diseases.
J Infect Dis. 2011;203:1-2.



48. BARTON RC.
Candida rugosa: a new fungal pathogen emerging, but from where?
J Med Microbiol. 2011.
ABSTRACT available


49. ROOD IG, de Korte D, Ramirez-Arcos S, Savelkoul PH, et al.
Distribution, origin and risk of coagulase negative staphylococci from platelet
concentrates.
J Med Microbiol. 2011.
ABSTRACT available


50. SAMBHAV K, Mathai A, Reddy AK, Reddy GV, et al.
Endogenous Endophthalmitis by Enterococcus casseliflavus.
J Med Microbiol. 2011.
ABSTRACT available


51. OYSTON PC, Davies C.
Q fever: the neglected biothreat agent.
J Med Microbiol. 2011;60.
ABSTRACT available


52. GLADSTONE RA, Jefferies JM, Faust SN, Clarke SC, et al.
Continued control of pneumococcal disease in the UK - the impact of vaccination.
J Med Microbiol. 2011;60.
ABSTRACT available


53. CROXALL G, Weston V, Joseph S, Manning G, et al.
Increased Human Pathogenic Potential of Escherichia coli from Polymicrobial
Urinary Tract Infections in Comparison to Isolates from Monomicrobial Culture
Samples.
J Med Microbiol. 2010.
ABSTRACT available


54. HOLMES NE, Opat S, Kelman A, Korman TM, et al.
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for
chronic lymphocytic leukaemia.
J Med Microbiol. 2011;60.
ABSTRACT available


55. GARZA-GONZALEZ E, Mendoza Ibarra SI, Llaca-Diaz JM, Gonzalez GM, et al.
Molecular characterization and antimicrobial susceptibility of extended-spectrum
{beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre
in Monterrey, Mexico.
J Med Microbiol. 2011;60.
ABSTRACT available


56. MORRIS K.
WHO recommends against inaccurate tuberculosis tests.
Lancet. 2011;377:113-4.



57. MARTINEAU AR, Timms PM, Bothamley GH, Hanifa Y, et al.
High-dose vitamin D(3) during intensive-phase antimicrobial treatment of
pulmonary tuberculosis: a double-blind randomised controlled trial.
Lancet. 2011.
ABSTRACT available


58. YAZDANBAKHSH M, Luty AJ.
Wormy mothers, healthy babies: case closed or conundrum?
Lancet. 2011;377:6-8.



59. ZUMLA A.
The white plague returns to London--with a vengeance.
Lancet. 2011;377:10-1.



60. BAUER MP, Notermans DW, van Benthem BH, Brazier JS, et al.
Clostridium difficile infection in Europe: a hospital-based survey.
Lancet. 2011;377:63-73.
ABSTRACT available


61. WARREN CA, Guerrant RL.
Pathogenic C difficile is here (and everywhere) to stay.
Lancet. 2011;377:8-9.



62. Salmonella montevideo infections associated with salami products made with
contaminated imported black and red pepper --- United States, July 2009-April
2010.
MMWR Morb Mortal Wkly Rep. 2010;59:1647-50.
ABSTRACT available


63. Transmission of multidrug-resistant Escherichia coli through kidney
transplantation --- California and Texas, 2009.
MMWR Morb Mortal Wkly Rep. 2010;59:1642-6.
ABSTRACT available


64. Update on cholera --- Haiti, Dominican Republic, and Florida, 2010.
MMWR Morb Mortal Wkly Rep. 2010;59:1637-41.
ABSTRACT available


65. HEINRICH N, Rachow A, Hoelscher M.
Rapid molecular detection of tuberculosis.
N Engl J Med. 2011;364:182.



66. BHANOT N.
Rapid molecular detection of tuberculosis.
N Engl J Med. 2011;364:183.



67. ZBINDEN A, Keller PM, Bloemberg GV.
Rapid molecular detection of tuberculosis.
N Engl J Med. 2011;364:183.



68. HESSELING AC, Graham SM, Cuevas LE.
Rapid molecular detection of tuberculosis.
N Engl J Med. 2011;364:183-4.



69. MOHAPATRA PR.
Rapid molecular detection of tuberculosis.
N Engl J Med. 2011;364:184.



70. MORAL L.
Smoke-free legislation and asthma.
N Engl J Med. 2011;364:87.



71. MILLER AL, Schissel S, Levy BD, Loscalzo J, et al.
Clinical problem-solving. A crazy cause of dyspnea.
N Engl J Med. 2011;364:72-7.



72. BADRI T, Ben Jennet S.
Images in clinical medicine. Rash associated with secondary syphilis.
N Engl J Med. 2011;364:71.



73. FRANCESCONI F, Francesconi V.
Images in clinical medicine. Lobomycosis.
N Engl J Med. 2011;364:e2.



74. ROESS AA, Galan A, Kitces E, Li Y, et al.
Novel deer-associated parapoxvirus infection in deer hunters.
N Engl J Med. 2010;363:2621-7.
ABSTRACT available


75. CHIN CS, Sorenson J, Harris JB, Robins WP, et al.
The origin of the Haitian cholera outbreak strain.
N Engl J Med. 2011;364:33-42.
ABSTRACT available


76. NELSON EJ, Nelson DS, Salam MA, Sack DA, et al.
Antibiotics for both moderate and severe cholera.
N Engl J Med. 2011;364:5-7.



77. WALTON DA, Ivers LC.
Responding to cholera in post-earthquake Haiti.
N Engl J Med. 2011;364:3-5.



78. KEESING F, Belden LK, Daszak P, Dobson A, et al.
Impacts of biodiversity on the emergence and transmission of infectious diseases.
Nature. 2010;468:647-52.
ABSTRACT available


79. SCEMLA A, Loupy A, Candon S, Mamzer MF, et al.
Incidence of Infectious Complications in Highly Sensitized Renal Transplant
Recipients Treated by Rituximab: A Case-Controlled Study.
Transplantation. 2010.
ABSTRACT available


_____________________ ** End ** ______________________



We have screened the following journals for you:
Am J Clin Pathol
Am J Med
Am J Pathol
Am J Public Health
Am J Respir Crit Care Med
Am J Trop Med Hyg
Ann Intern Med
Antimicrob Agents Chemother
Arch Intern Med
Biochemistry
BMJ
Cancer
Chemotherapy
Chest
Clin Infect Dis
Curr Microbiol
Diagn Microbiol Infect Dis
Dig Dis Sci
Drugs
Dtsch Med Wochenschr
Eur J Clin Microbiol Infect Dis
Infect Immun
Int J Cancer
Internist
J Antimicrob Chemother
J Bacteriol
J Biol Chem
J Clin Invest
J Clin Microbiol
J Immunol
J Infect Dis
J Med Chem
J Med Microbiol
J Urol
J Virol
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Nat Med
Nature
Neurology
Pediatrics
Proc Natl Acad Sci U S A
Science
Transplantation

_________________________________________________________

AMEDEO HIV Infection: Your January Journal Article Summary

AMEDEO HIV Infection

2011-01-17

This E-mail is produced by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim


________________ ** New articles **  _________________


1. SOULIE C, Fourati S, Lambert-Niclot S, Tubiana R, et al.
HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV
encephalitis.
AIDS. 2010;24:2412-4.
ABSTRACT available


2. HUMPHREY J, Koyanagi A, Moulton LH, Ntozini R, et al.
PREDICTIVE VALUE OF WEIGHT LOSS ON MORTALITY OF HIV-POSITIVE MOTHERS IN A
PROLONGED BREASTFEEDING SETTING.
AIDS Res Hum Retroviruses. 2011.
ABSTRACT available


3. REVILLA A, Delgado E, Christian EC, Dalrymple J, et al.
Construction and phenotypic characterization of HIV-1 functional envelope clones
of subtypes G and F.
AIDS Res Hum Retroviruses. 2011.
ABSTRACT available


4. PYNE JM, Fortney JC, Curran GM, Tripathi S, et al.
Effectiveness of collaborative care for depression in human immunodeficiency
virus clinics.
Arch Intern Med. 2011;171:23-31.
ABSTRACT available


5. LEE DH, Vielemeyer O.
Analysis of overall level of evidence behind infectious diseases society of
america practice guidelines.
Arch Intern Med. 2011;171:18-22.
ABSTRACT available


6. SOUZA TM, Rodrigues DQ, Passaes CP, Barreto-de-Souza V, et al.
The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1
transcription and replication in human primary macrophages.
Blood. 2011.
ABSTRACT available


7. KOUYOS RD, von Wyl V, Yerly S, Boni J, et al.
Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker
for Viral Diversity and the Age of Infection.
Clin Infect Dis. 2011.
ABSTRACT available


8. MARX PA, Drucker EM, Schneider WH.
The Serial Passage Theory of HIV Emergence.
Clin Infect Dis. 2011;52:421.



9. DAO CN, Patel P, Overton ET, Rhame F, et al.
Low Vitamin D among HIV-Infected Adults: Prevalence of and Risk Factors for Low
Vitamin D Levels in a Cohort of HIV-Infected Adults and Comparison to Prevalence
among Adults in the US General Population.
Clin Infect Dis. 2011;52:396-405.
ABSTRACT available


10. MONDY KE, Gottdiener J, Overton ET, Henry K, et al.
High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in
the Era of Highly Active Antiretroviral Therapy.
Clin Infect Dis. 2011;52:378-386.
ABSTRACT available


11. LEVINE MM, Farag TH.
Invasive Salmonella Infections and HIV in Northern Tanzania.
Clin Infect Dis. 2011;52:349-51.



12. CRUMP JA, Ramadhani HO, Morrissey AB, Saganda W, et al.
Invasive Bacterial and Fungal Infections Among Hospitalized HIV-Infected and
HIV-Uninfected Adults and Adolescents in Northern Tanzania.
Clin Infect Dis. 2011;52:341-8.
ABSTRACT available


13. GOSTIN LO, Kim SC.
Ethical allocation of preexposure HIV prophylaxis.
JAMA. 2011;305:191-2.



14. BRAUN M, Kabue MM, McCollum ED, Ahmed S, et al.
Inadequate Coordination of Maternal and Infant HIV Services Detrimentally Affects
Early Infant Diagnosis Outcomes in Lilongwe, Malawi.
J Acquir Immune Defic Syndr. 2011.
ABSTRACT available


15. ARNSTEN JH, Litwin AH, Berg KM.
Effect of directly observed therapy for highly active antiretroviral therapy on
virologic, immunologic, and adherence outcomes: a meta-analysis and systematic
review.
J Acquir Immune Defic Syndr. 2011;56:e33-4.



16. KOON HB, Fingleton B, Lee JY, Geyer JT, et al.
Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related
Kaposi sarcoma.
J Acquir Immune Defic Syndr. 2011;56:64-8.
ABSTRACT available


17. LIN Q, Fang D, Hou X, Le Y, et al.
HCV Peptide (C5A), an Amphipathic {alpha}-Helical Peptide of Hepatitis Virus C,
Is an Activator of N-Formyl Peptide Receptor in Human Phagocytes.
J Immunol. 2011.
ABSTRACT available


18. WHITE MK, Khalili K.
Pathogenesis of Progressive Multifocal Leukoencephalopathy--Revisited.
J Infect Dis. 2011.
ABSTRACT available


19. ORTIZ M, Poloni ES, Furrer H, Kovari H, et al.
No Longitudinal Mitochondrial DNA Sequence Changes in HIV-infected Individuals
With and Without Lipoatrophy.
J Infect Dis. 2011.
ABSTRACT available


20. JOHNSON KE, Redd AD, Quinn TC, Collinson-Streng AN, et al.
Effects of HIV-1 and Herpes Simplex Virus Type 2 Infection on Lymphocyte and
Dendritic Cell Density in Adult Foreskins from Rakai, Uganda.
J Infect Dis. 2011.
ABSTRACT available


21. TRIANT VA, Grinspoon SK.
Immune Dysregulation and Vascular Risk in HIV-Infected Patients: Implications for
Clinical Care.
J Infect Dis. 2011.



22. REDD AD, Gray RH, Quinn TC.
Is Microbial Translocation a Cause or Consequence of HIV Disease Progression?
J Infect Dis. 2011.



23. KAPLAN RC, Sinclair E, Landay AL, Lurain N, et al.
T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in
HIV-Infected Women.
J Infect Dis. 2011.
ABSTRACT available


24. MERINO A, Malhotra R, Morton M, Mulenga J, et al.
Impact of a Functional KIR2DS4 Allele on Heterosexual HIV-1 Transmission among
Discordant Zambian Couples.
J Infect Dis. 2011.
ABSTRACT available


25. WANG C, Wright TC, Denny L, Kuhn L, et al.
Rapid Rise in Detection of Human Papillomavirus (HPV) Infection Soon After
Incident HIV Infection Among South African Women.
J Infect Dis. 2011.
ABSTRACT available


26. KAPITO-TEMBO A, Meshnick SR, van Hensbroek MB, Phiri K, et al.
Marked Reduction in Prevalence of Malaria Parasitemia and Anemia in HIV-Infected
Pregnant Women Taking Cotrimoxazole With Or Without Sulfadoxine-Pyrimethamine
Intermittent Preventive Therapy during Pregnancy in Malawi.
J Infect Dis. 2011.
ABSTRACT available


27. ALPERT MD, Rahmberg AR, Neidermyer W, Ng SK, et al.
Envelope-modified single-cycle simian immunodeficiency virus selectively enhances
antibody responses and partially protects against repeated, low-dose vaginal
challenge.
J Virol. 2010;84:10748-64.
ABSTRACT available


28. JOHN TJ, Dandona L, Sharma VP, Kakkar M, et al.
Continuing challenge of infectious diseases in India.
Lancet. 2011.
ABSTRACT available


29. GROVER A, Citro B.
India: access to affordable drugs and the right to health.
Lancet. 2011.



30. WAWER MJ, Tobian AA, Kigozi G, Kong X, et al.
Effect of circumcision of HIV-negative men on transmission of human
papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda.
Lancet. 2011.
ABSTRACT available


31. The ART of preventing HIV.
Nat Med. 2011;17:46-7.



32. Breakthrough of the year. The runners-up.
Science. 2010;330:1605-7.



33. AGARWAL A, Hioe CE, Swetnam J, Zolla-Pazner S, et al.
Quantitative assessment of masking of neutralization epitopes in HIV-1.
Vaccine. 2011.
ABSTRACT available


34. KEEFER MC, Frey SE, Elizaga M, Metch B, et al.
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors
containing matching HIV-1 inserts in healthy HIV-uninfected subjects.
Vaccine. 2011.
ABSTRACT available


35. PALMA P, Romiti ML, Li Pira G, Montesano C, et al.
The PEDVAC trial: Preliminary data from the first therapeutic DNA vaccination in
HIV-infected children.
Vaccine. 2011.
ABSTRACT available


36. KITYO C, Bousheri S, Akao J, Ssali F, et al.
Therapeutic immunization in HIV infected Ugandans receiving stable antiretroviral
treatment: A Phase I safety study.
Vaccine. 2011.
ABSTRACT available


37. LI X, Krishnan L, Cherepanov P, Engelman A, et al.
Structural biology of retroviral DNA integration.
Virology. 2011.
ABSTRACT available


38. STERJOVSKI J, Churchill MJ, Roche M, Ellett A, et al.
CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4
interactions and fusogenicity.
Virology. 2011.
ABSTRACT available


_____________________ ** End ** ______________________



We have screened the following journals for you:
AIDS
AIDS Clin Care
AIDS Read
AIDS Res Hum Retroviruses
Am J Epidemiol
Am J Hematol
Am J Med
Ann Intern Med
Ann Neurol
Antimicrob Agents Chemother
Antivir Ther
Arch Dermatol
Arch Dis Child
Arch Intern Med
Arch Neurol
Blood
BMJ
Br J Dermatol
Br J Haematol
Cancer
Cell
Clin Infect Dis
Dermatology
Drugs
HIV Med
Immunology
Int J Cancer
Int J Dermatol
J Acquir Immune Defic Syndr
J Am Acad Dermatol
J Clin Immunol
J Clin Invest
J Clin Oncol
J Immunol
J Infect Dis
J Med Virol
J Pediatr
J Virol
JAMA
Lancet
MMWR
N Engl J Med
Nat Med
Nature
Neurology
Pediatr Infect Dis J
Pediatrics
Proc Natl Acad Sci U S A
Scand J Infect Dis
Science
Vaccine
Virology

_________________________________________________________

Research - Pregnancy Disorders 2011-01-17

AMEDEO Pregnancy Disorders


2011-01-17


________________ ** New articles **  _________________


1. LEE BE, Park H, Park EA, Gwak H, et al.
Paraoxonase 1 gene and glutathione S-transferase mu 1 gene interaction with
preterm delivery in Korean women.
Am J Obstet Gynecol. 2010;203:569.
ABSTRACT available


2. MACONES GA, McNamara J, Wallenstein M, Squires K, et al.
Discussion: 'Congenital toxoplasmosis' by Berrebi et al.
Am J Obstet Gynecol. 2010;203:e1-3.
ABSTRACT available


3. SCOTET V, Dugueperoux I, Audrezet MP, Audebert-Bellanger S, et al.
Focus on cystic fibrosis and other disorders evidenced in fetuses with
sonographic finding of echogenic bowel: 16-year report from Brittany, France.
Am J Obstet Gynecol. 2010;203:592.
ABSTRACT available


4. WINTERMARK P, Boyd T, Gregas MC, Labrecque M, et al.
Placental pathology in asphyxiated newborns meeting the criteria for therapeutic
hypothermia.
Am J Obstet Gynecol. 2010.
ABSTRACT available


5. FOGLIA LM, Ippolito DL, Stallings JD, Zelig CM, et al.
Intramuscular 17alpha-hydroxyprogesterone caproate administration attenuates
immunoresponsiveness of maternal peripheral blood mononuclear cells.
Am J Obstet Gynecol. 2010;203:561.
ABSTRACT available


6. HAAVALDSEN C, Sarfraz AA, Samuelsen SO, Eskild A, et al.
The impact of maternal age on fetal death: does length of gestation matter?
Am J Obstet Gynecol. 2010;203:554.
ABSTRACT available


7. JUNGHEIM ES, Moley KH.
Current knowledge of obesity's effects in the pre- and periconceptional periods
and avenues for future research.
Am J Obstet Gynecol. 2010;203:525-30.
ABSTRACT available


8. SALOMON LJ, Ville Y, Khen-Dunlop N.
The meaning of intraabdominal bowel dilation in fetuses with gastroschisis.
Am J Obstet Gynecol. 2010;203:e9-10.



9. BERREBI A, Assouline C, Bessieres MH, Lathiere M, et al.
Long-term outcome of children with congenital toxoplasmosis.
Am J Obstet Gynecol. 2010.
ABSTRACT available


10. TAM KF, Cheung AN, Szeto E, Ngan HY, et al.
Atypical glandular cells diagnosed during pregnancy and the postpartum period: a
retrospective analysis.
Eur J Obstet Gynecol Reprod Biol. 2011.
ABSTRACT available


11. CHELCHOWSKA M, Ambroszkiewicz J, Gajewska J, Laskowska-Klita T, et al.
The effect of tobacco smoking during pregnancy on plasma oxidant and antioxidant
status in mother and newborn.
Eur J Obstet Gynecol Reprod Biol. 2011.
ABSTRACT available


12. WELMERINK DB, Voigt LF, Daling JR, Mueller BA, et al.
Infertility treatment use in relation to selected adverse birth outcomes.
Fertil Steril. 2010;94:2580-6.
ABSTRACT available


13. ZAKARIA MA, Abdallah ME, Shavell VI, Berman JM, et al.
Conservative management of cervical ectopic pregnancy: utility of uterine artery
embolization.
Fertil Steril. 2011.
ABSTRACT available


14. COURBIERE B, Oborski V, Braunstein D, Desparoir A, et al.
Obstetric outcome of women with in vitro fertilization pregnancies hospitalized
for ovarian hyperstimulation syndrome: a case-control study.
Fertil Steril. 2011.
ABSTRACT available


15. MUSTERS AM, Repping S, Korevaar JC, Mastenbroek S, et al.
Pregnancy outcome after preimplantation genetic screening or natural conception
in couples with unexplained recurrent miscarriage: a systematic review of the
best available evidence.
Fertil Steril. 2011.
ABSTRACT available


16. GNISCI A, Rua S, Coubiere B, Cravello L, et al.
Plasma creatine phosphokinase level may predict successful treatment after a
single injection of methotrexate for ectopic pregnancy.
Fertil Steril. 2011.
ABSTRACT available


17. FRIEDLER S, Glasser S, Azani L, Freedman LS, et al.
The effect of medical clowning on pregnancy rates after in vitro fertilization
and embryo transfer (IVF-ET).
Fertil Steril. 2011.
ABSTRACT available


18. TARTAKOVER-MATALON S, Mizrahi A, Epstein G, Shneifi A, et al.
Breast cancer characteristics are modified by first trimester human placenta: in
vitro co-culture study.
Hum Reprod. 2010.
ABSTRACT available


19. LEE CL, Chiu PC, Lam KK, Siu SO, et al.
Differential actions of glycodelin-A on Th-1 and Th-2 cells: a paracrine
mechanism that could produce the Th-2 dominant environment during pregnancy.
Hum Reprod. 2011.
ABSTRACT available


20. LEM AJ, Boonstra VH, Renes JS, Breukhoven PE, et al.
Anti-Mullerian hormone in short girls born small for gestational age and the
effect of growth hormone treatment.
Hum Reprod. 2011.
ABSTRACT available


21. KUEHN BM.
Report promotes depression screening for mothers during pediatric visits.
JAMA. 2011;305:26-7.



22. YAZDANBAKHSH M, Luty AJ.
Wormy mothers, healthy babies: case closed or conundrum?
Lancet. 2011;377:6-8.



_____________________ ** End ** ______________________



We have screened the following journals for you:
Acta Obstet Gynecol Scand
Am J Obstet Gynecol
Am J Public Health
Ann N Y Acad Sci
Aust N Z J Obstet Gynaecol
Birth
BMJ
Clin Exp Obstet Gynecol
Clin Obstet Gynecol
Curr Opin Obstet Gynecol
Epidemiology
Eur J Obstet Gynecol Reprod Biol
Fertil Steril
Gynecol Obstet Invest
Hum Reprod
Int J Gynaecol Obstet
JAMA
Lancet
N Engl J Med
Obstet Gynecol

_________________________________________________________

Wednesday, January 5, 2011

Natural products for malaria vector control: flora, fish and fungi

Natural products for malaria vector control: flora, fish and fungi



Below is the abstract and summary of the PhD thesis of Annabel Howard. She graduated in October from Wageningen University on her thesis with the above title.
Currently, Annabel is preparing to move to Angola. Interested parties can contact her for collaborative activities in the field of malaria.
Abstract
 
Introduction
Despite international organisations providing much focus over the past 10 years, malaria is still killing vast numbers of Africans, especially children. It is agreed that malaria can only be successfully controlled by using different control tools simultaneously in the spirit of integrated vector management (IVM), and that African communities will need to become more directly involved in mosquito control. Using mosquito control tools in a way that requires almost no technical equipment or knowledge will open them up to the rural communities that are best placed to deploy them. In addition, widespread insecticide resistance is reducing the ability of insecticide-based tools to control mosquitoes. For these reasons, biological control and other natural mosquito control methods are being researched by many institutions. Several potential natural control tools are readily available in sub-Saharan Africa. If these tools prove effective and become operational, then it is possible that they will be sustainable because communities can intentionally produce the biological agents themselves, bringing a source of money to rural communities. This would be especially important in areas where infrastructure is poorly developed, and repeat applications of chemical control tools are not easily made. This thesis was designed to test the feasibility and effectiveness of a variety of natural products against both larval and adult malaria vector mosquitoes using low-tech methods in laboratory and field trials. 
 
Part I: Flora
Azadirachta indica A. Juss (Meliaceae) (the neem tree) was chosen due to the already proved mosquitocidal properties, and its ready availability in Africa. We wanted to use neem in a way that could easily be deployed in resource-poor rural areas. Laboratory studies were conducted to examine the larvicidal and pupicidal properties of a crude aqueous extract of neem wood against the principle African malaria vector, Anopheles gambiae Giles s.s. (Diptera: Culicidae) [1]. The results indicate that even a relatively low dose of 0.15 grams of dried neem wood in 1 litre of water was able to inhibit the emergence of 90% of mosquito adults when larvae were exposed during their first three larval instars. Even for the fourth (last) larval instar, just 0.6 g/l was required to prevent 90% emergence. Furthermore, neem-exposed larvae exhibited significantly increased development times when compared to the controls. Pupae were also killed by the aqueous neem extracts, and were subject to neem-induced emergence abnormalities, but the concentrations required to kill pupae were much higher than for larvae and not likely to be used operationally. High performance liquid chromatography (HPLC) analysis identified several polar constituents in the aqueous neem extracts including nimbin and salannin. However, azadirachtin was not present in significant amounts. The effect of this extract on the oviposition behaviour of adult female An. gambiae s.s. mosquitoes was then monitored [2]. The oviposition results show that when using 0.1 g/l of the crude aqueous neem extract, no significant effects on oviposition behaviour was found. This was also the case when using neem doses 10x and 100x higher, indicating that even at much higher doses than required for successful larval control, female oviposition will not be detrimentally affected.
 
Part II: Fish
Larvivorous fish have previously been shown to effectively control mosquito numbers. Therefore, a census was carried out to examine the current status of fish farming in western Kenya [3]. Working with the Kenyan Fisheries Department we found that while fish farming is a favoured activity, 30% of the 261 ponds found did not contain fish. These “abandoned” ponds had significantly more An. gambiae s.l., Anopheles funestus Giles and culicine mosquitoes when compared to the ponds that still contained fish. Furthermore, An. gambiae s.l. was proportionally more abundant in the abandoned ponds when compared to the other mosquito types. Surprisingly, vegetation did not significantly affect mosquito distribution. Following our study, demand for fish to restock abandoned ponds increased by 67% when compared to the previous year. The overwhelming majority of fish being farmed in our census area were fish of the tilapiine subfamily. Given this finding, we set up a small-scale field experiment to study the larvivorous potential of the tilapiine fish Oreochromis niloticus L. (Perciformes: Cichlidae) [4]. Taking daily measurements of mosquito numbers, we found that immediately after fish introduction, the density of mosquitoes in the treated ponds dropped in comparison to the increase in the control pond. After 15 weeks, anopheline numbers had decreased by >94% in the ponds containing the fish, and we found that fish were able to sustainably control mosquitoes for at least 6 months, when our study finished. It is concluded that this type of fish could be an effective and sustainable way to control mosquito numbers in rural western Kenya. Furthermore, this fish provides a source of much needed income and protein to rural African communities.
 
Part III: Fungi
For the control of mosquito adults using natural products, entomopathogenic fungi hold the most promise. In this thesis the entomopathogenic fungi Beauveria bassiana and Metarhizium anisopliae were separately suspended in mineral oil and applied to polyester netting. A laboratory experiment was then conducted to investigate the fungal susceptibility of insecticide-susceptible and insecticide-resistant strains of An. gambiae s.s.. In addition, fungal conidial viability was tested at various time points after application onto polyester netting [5]. Whilst both mosquito strains were susceptible to both species of fungal infection, the pyrethroid-resistant An. gambiae s.s. VKPER strain was significantly more susceptible than the insecticide-susceptible SKK strain, dying more quickly. Conidial viability was significantly lower for both species after application onto the polyester netting when compared to the viability in suspension. However, the ability of the treated netting to infect and kill mosquitoes was not significantly diminished over the one week trial period. 
Given the finding that fungal-treated polyester netting could infect and kill mosquitoes, an experimental hut field trial was conducted in Benin, West Africa, to investigate the effect of fungal treatment on blood feeding behaviour and survival of wild insecticide-resistant mosquitoes. Benin was chosen due to the presence of multi-insecticide-resistant mosquito populations that are threatening the effectiveness of current vector control. We used fungal-treated netting to infect mosquitoes entering the hut windows, and either an untreated or insecticide-treated bednet was placed into each hut to examine how the entomopathogenic fungi would work with current control tools [6]. Only enough Culex quinquefasciatus Say (Diptera: Culicidae) mosquitoes were collected from the huts for accurate analysis. Our study was the first to monitor the effect of entomopathogenic fungi on blood feeding of wild mosquitoes. We found that the B. bassiana treatments caused significant and instantaneous reductions in blood feeding; no significant effect of the fungi on mosquito mortality was found [6]. In concurrent studies, colony An. gambiae s.s. VKPER strain mosquitoes were infected with B. bassiana conidia that had been applied to polyester netting and kept under field conditions. The results show that B. bassiana infection caused significantly increased mortality to the exposed mosquitoes. However, the virulence and viability of the B. bassiana conidia decreased with increasing time spent exposed to the field conditions [7].  
 
Conclusions
This thesis used several different experimental techniques to examine the potential of three natural products to control mosquitoes. For the flora, it was found that even a small amount of neem wood in water would control mosquitoes, and at this and higher doses, the oviposition behaviour was not adversely affected. Neem trees are readily available in many areas of Africa, and promising field trials indicate that the use of this tree species should be incorporated into malaria control trials. 
This thesis reports that edible native African fish can be effective at controlling mosquitoes, but if fish farming is abandoned and the ponds not filled in, then they can allow large numbers of the most effective malaria vectors to breed. Fish have been successfully used for malaria vector control in many countries and this could be rolled out across appropriate areas of Africa, as long as it is accompanied with adequate education about the dangers of abandoned ponds. 
We found that insecticide-resistant mosquitoes were more susceptible to fungal infection than the insecticide-susceptible strain. Under field conditions fungi were able to prevent blood feeding but did not cause significant mortality in the wild-caught mosquitoes. Although entomopathogenic fungi produce high levels of mortality in laboratory settings, their use under field conditions still has a long way to go and is not yet at the operational stage. Although the results found in this thesis are encouraging for the use of fungi in African situations, further work should be carried out to maximise fungal persistence under field conditions. 
The current emphasis is on IVM for malaria control, and focus is turning to biological control tools that can help manage insecticide-resistant populations. With this in mind, the natural products investigated in this thesis have produced encouraging results that show they have the potential to be integrated into malaria control strategies. Furthermore, flora and fish are readily available in the areas where they are most required, and could be used almost immediately to help reduce mosquito numbers and correspondingly, malaria disease transmission. 
 
 
1. Howard AFV, Adongo EA, Hassanali A, Omlin FX, Wanjoya A, Zhou G, Vulule J: Laboratory evaluation of the aqueous extract of Azadirachta indica (neem) wood chippings on Anopheles gambiae s.s. (Diptera: Culicidae) mosquitoes. J Med Entomol 2009, 46(1):107-114.
2. Howard AFV, Adongo EA, Vulule J, Githure J: Effects of a botanical larvicide derived from Azadirachta indica (the neem tree) on oviposition behaviour in Anopheles gambiae s.s. mosquitoes. Under Review.
3. Howard AFV, Omlin FX: Abandoning small-scale fish farming in western Kenya leads to higher malaria vector abundance. Acta Trop 2008, 105(1):67-73.
4. Howard AFV, Zhou G, Omlin FX: Malaria mosquito control using edible fish in western Kenya: preliminary findings of a controlled study. BMC Publ Health 2007, 7:199.
5. Howard AFV, Koenraadt CJM, Farenhorst M, Knols BGJ, Takken W: Pyrethroid resistance in Anopheles gambiae leads to increased susceptibility to the entomopathogenic fungi Metarhizium anisopliae and Beauveria bassiana. Malar J 2010, 9:168.
6. Howard AFV, N'Guessan R, Koenraadt CJM, Asidi A, Farenhorst M, Akogbeto M, Thomas MB, Knols BGJ, Takken W: The entomopathogenic fungus Beauveria bassiana reduces instantaneous blood feeding in wild multi-insecticide-resistant mosquitoes in Benin, West Africa. Parasit Vectors 2010, 3:87.
7. Howard AFV, N'Guessan R, Koenraadt CJM, Asidi A, Farenhorst M, Akogbeto M, Knols BGJ, Takken W: First report of the infection of insecticide-resistant malaria vector mosquitoes with an entomopathogenic fungus under field conditions. Under Review.